• 12359 - Hebert
    PHASE 3 POOLED ANALYSIS OF SAFETY AND EFFICACY OF TRIFAROTENE 0.005% CREAM WITHIN ADOLESCENT POPULATION
    Adelaide Hebert, MD; Stephanie Lee, MD; Daniel Krowchuk, MD; Krysten L. Arekapudi, DNP; Pearl Kwong, MD
    Poster Abstract

  • 12360 - Hsiao
    Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Pooled Subgroup Analysis From the SUNSHINE and SUNRISE Phase 3 Trials
    Jennifer L. Hsiao, Vivian Y. Shi, Stephanie Mehlis, Julia M. Riley, John Darcy II, Xiaoling Wei, Elisa Muscianisi
    Poster Abstract

  • 12361 - Hsu
    Remibrutinib treatment improves itch and sleep in chronic spontaneous urticaria patients: Phase 2b study results
    Connie Hsu, Robert Snyder, Lee Clore, Vipul Jain, Ana Giménez-Arnau, Karine Lheritier, Pauline Walsh, Sibylle Haemmerle, Michael Wells, Ivan Nikolaev, Marcus Maurer
    Poster Abstract

  • 12362 - Hu
    Real-world use of ruxolitinib cream: safety analysis at 1 year
    Wilson Hu, Michele Thornton, Robert A. Livingston
    Poster Abstract

  • 12363 - Hyams
    Combining the 31-gene expression profile test for cutaneous melanoma with the American Joint Committee on Cancer staging identifies the highest-risk patients with stage I-II disease
    David Hyams, MD, Jung Byun, PhD, MPH, Brian Martin, PhD, Christine N. Bailey, MPH, Timothy Stumpf, Valentina Petkov, MD, MPH
    Poster Abstract

  • 12365 - Ingram
    Clinical burden of hidradenitis suppurativa with draining tunnels
    John R. Ingram, Gregor B.E. Jemec, Angelo V. Marzano, Errol Prens, Sylke Schneider-Burrus, Isabel Truman, Ana Cristina Hernandez-Daly, Robin Jha, Hyemin Song, Alexa B. Kimball
    Poster Abstract

  • 12366 - Jacobson
    Fixed-Combination Halobetasol Propionate and Tazarotene Topical Lotion Decreases Interleukin-17A Levels in Psoriasis
    Zoe Draelos, Matthew Draelos, Tina Lin, Abby Jacobson
    Poster Abstract

  • 12317 - Kimball
    Bimekizumab in patients with moderate-to-severe hidradenitis suppurativa: 48-week efficacy and safety from BE HEARD I & II, two phase 3, randomized, double‑blind, placebo‑controlled, multicenter studies
    Christos C. Zouboulis, Christopher Sayed, Joslyn S. Kirby, Errol Prens, John R. Ingram, Amit Garg, Robert Rolleri, Edward Muller, Paulatsya Joshi, Gregor Jemec
    Poster Abstract

  • 12367 - King
    Safety Analysis of Baricitinib in Adult Patients With Severe Alopecia Areata From 2 Randomized Clinical Trials Over a Median of 1.6 Years and up to 3.6 Years of Exposure
    Brett King, Justin Ko, Bianca Maria Piraccini, Yutaka Shimomura, Yves Dutronc, Wen-Shuo Wu, Fan Emily Yang, Katrin Holzwarth, Chiara Chiasserini, Rodney Sinclair
    Poster Abstract

  • 12368 - Kirby
    Impact of draining tunnels on patient- and physician-reported burden in patients with hidradenitis suppurativa
    Joslyn Kirby, Iltefat Hamzavi, Axel P. Villani, Richard B. Warren, Aaron Keal, Ana C. Hernandez-Daly, Robin Jha, Hyemin Song, Alexa B. Kimball
    Poster Abstract

  • 12369 - Kircik
    Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis
    Leon Kircik, Matthew Zirwas, Shawn G. Kwatra, G. Michael Lewitt, Holly Glover, Tomas Chao, Philip M. Brown, David S. Rubenstein, Anna M. Tallman
    Poster Abstract

  • 12370 - Ko
    Clinical Outcomes for Up-Titration with Baricitinib Therapy in Patients with Severe Alopecia Areata from BRAVE-AA1 and BRAVE-AA2
    Justin Ko, Tiffany T Mayo, Wilma F Bergfeld, Yves Dutronc, Wen-Shuo Wu, Guanglei Yu, Susan G Ball, Najwa Somani, Brittany Craiglow
    Poster Abstract

  • 12371 - Korman
    Deucravacitinib in plaque psoriasis: 2-year laboratory results from the phase 3 POETYK PSO program
    Neil J. Korman, Thierry Passeron, Kenneth B. Gordon, Yukari Okubo, Jerry Bagel, Howard Sofen, Richard B. Warren, Lynda Spelman, Lauren Hippeli, Subhashis Banerjee, Diamant Thaçi
    Poster Abstract

  • 12372 - Kwatra
    Dupilumab Improves Itch, Skin Pain, and Sleep in Adult Patients with Prurigo Nodularis (LIBERTY PN-PRIME and PRIME2)
    Kwatra SG, Yosipovitch G, Stander S, Guillemin I, Msihid J, Wiggins S, Levit NA, Bansal A, O’Malley JT, Bahloul D, Thomas R
    Poster Abstract

  • 12373 - Kwatra
    Development of a patient-centered conceptual disease model for prurigo nodularis: a qualitative content analysis
    Shawn G. Kwatra, MD; C. Dias-Barbosa, MSc; D. Rodriguez, PhD; F. Zeng, MSPH; Gabriel Sylvie, MD; Christophe Piketty, MD; J. Puelles, PharmD
    Poster Abstract

  • 12374 - Kwatra
    Nemolizumab monotherapy improves itch, skin lesions, and sleep disturbance in patients with prurigo nodularis: Results from a phase 3 trial (OLYMPIA 2)
    Shawn G. Kwatra, MD, Gil Yosipovitch, MD, Franz J. Legat, MD, Adam Reich, MD, Carle Paul, MD, Dagmar Simon, MD, Luigi Naldi, MD, Faiz Ahmad, MS, Zarif Jabbar Lopez, MBBS, MPH, Christophe Piketty, MD, Sonja Ständer, MD
    Poster Abstract

  • 12375 - Lebwohl
    Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults with Chronic Plaque Psoriasis From a 52-Week, Phase 2 Open-Label Safety Trial
    Mark Lebwohl, Linda Stein Gold, Melinda J. Gooderham, Kim A. Papp, Laura K. Ferris, David N. Adam, H. Chih-ho Hong, Leon H. Kircik, Matthew Zirwas, Patrick Burnett, Robert Higham,David Krupa, David Berk
    Poster Abstract

  • 12376 - Lebwohl
    Long-Term Safety of Ixekizumab Treatment in Adult Patients With Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: A Post-Hoc Analysis of End-of-Study Program Data Relating to Major Adverse Cardiovascular Events
    Mark Lebwohl, Atul Deodhar, Sergio Schwartzman, Carlo Salvarani, Meghan Feely, Danting Zhu, Proton Rahman, Kim A. Papp, Joseph F. Merola, Alice B. Gottlieb, Andrew Blauvelt
    Poster Abstract

  • 12378 - Lebwohl
    Brodalumab: 4-Year US Pharmacovigilance Report
    Mark Lebwohl, Andrea Murina, George Han, Abby Jacobson
    Poster Abstract

  • 12377 - Leffell
    The Effectiveness of a Handheld Elastic Scattering Spectroscopy (ESS) Device in Detecting Melanoma and Non-Melanoma Skin Cancers: Pooled Analysis of Two Prospective, Multi-center Clinical Trials
    David Leffell, MD; Holly Christman, MD; Todd Thames, MD; John Geisse, MD; Harold Rabinovitz, MD; Kiran Chatha, MD, MPH; Vivien L Nguyen, PharmD; Jane M Grant-Kels, MD
    Poster Abstract